Extrapulmonary Neuroendocrine Carcinoma
📧 Sign up to get email alerts when something new happens for Extrapulmonary Neuroendocrine Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: TAS-102 in Extrapulmonary Neuroendocrine Carcinoma [Phase 2]
Phase 2 trial of TAS-102 for extrapulmonary neuroendocrine carcinoma was terminated.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Nab-paclitaxel Combined with Bevacizumab in the Treatment of Metastatic Extrapulmonary Neuroendocrine Carcinoma [Phase 2]
A Phase 2 trial evaluating nab-paclitaxel in combination with bevacizumab for metastatic extrapulmonary neuroendocrine carcinoma has complet…
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas [Phase 2]
Phase 2 trial evaluating camrelizumab with chemotherapy and apatinib in extrapulmonary neuroendocrine carcinomas is ongoing with unknown sta…